- call +1-201-465-4211
- email sales@mrinsights.biz
Smoking cessation (also known as quitting smoking or simply quitting) is the process of discontinuing tobacco smoking. Tobacco smoke contains nicotine, which is addictive. Nicotine withdrawal makes the process of quitting often very prolonged and difficult.
Scope of the Report:
This report focuses on the Smoking Cessation Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Americas accounted for almost 42% of the market share and is expected to grow at a CAGR of around 13% during the forecast period. The decline in smoker’s population due to rising health consciousness and the increased preference for the use of e-cigarettes and nicotine replacement therapy products are the primary drivers for the market growth in this region.
The worldwide market for Smoking Cessation Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
GSK
Pfizer
Kimree Technology
Johnson & Johnson
Novartis
Dr. Reddy's Laboratories
The Harvard Drug Group
Perrigo Company
Fontem Ventures
Smoke Away
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
NRTs Products
Nicotine-Free Products
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
There are 15 Chapters to deeply display the global Smoking Cessation Drugs market.
Chapter 1, to describe Smoking Cessation Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Smoking Cessation Drugs, with sales, revenue, and price of Smoking Cessation Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Smoking Cessation Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Smoking Cessation Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Smoking Cessation Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Smoking Cessation Drugs Introduction
1.2 Market Analysis by Type
1.2.1 NRTs Products
1.2.2 Nicotine-Free Products
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 Business Overview
2.1.2 Smoking Cessation Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GSK Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Smoking Cessation Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Kimree Technology
2.3.1 Business Overview
2.3.2 Smoking Cessation Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Kimree Technology Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Smoking Cessation Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Smoking Cessation Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Dr. Reddy's Laboratories
2.6.1 Business Overview
2.6.2 Smoking Cessation Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Dr. Reddy's Laboratories Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 The Harvard Drug Group
2.7.1 Business Overview
2.7.2 Smoking Cessation Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 The Harvard Drug Group Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Perrigo Company
2.8.1 Business Overview
2.8.2 Smoking Cessation Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Perrigo Company Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Fontem Ventures
2.9.1 Business Overview
2.9.2 Smoking Cessation Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Fontem Ventures Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Smoke Away
2.10.1 Business Overview
2.10.2 Smoking Cessation Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Smoke Away Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Smoking Cessation Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Smoking Cessation Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Smoking Cessation Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Smoking Cessation Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Smoking Cessation Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Smoking Cessation Drugs Market Analysis by Regions
4.1 Global Smoking Cessation Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Smoking Cessation Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Smoking Cessation Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
4.5 South America Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
5 North America Smoking Cessation Drugs by Countries
5.1 North America Smoking Cessation Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Smoking Cessation Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Smoking Cessation Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
6 Europe Smoking Cessation Drugs by Countries
6.1 Europe Smoking Cessation Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Smoking Cessation Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Smoking Cessation Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
6.3 UK Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
6.4 France Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Smoking Cessation Drugs by Countries
7.1 Asia-Pacific Smoking Cessation Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Smoking Cessation Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Smoking Cessation Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
7.5 India Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
8 South America Smoking Cessation Drugs by Countries
8.1 South America Smoking Cessation Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Smoking Cessation Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Smoking Cessation Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Smoking Cessation Drugs by Countries
9.1 Middle East and Africa Smoking Cessation Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Smoking Cessation Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Smoking Cessation Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Smoking Cessation Drugs Sales and Growth Rate (2013-2018)
10 Global Smoking Cessation Drugs Market Segment by Type
10.1 Global Smoking Cessation Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Smoking Cessation Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Smoking Cessation Drugs Revenue and Market Share by Type (2013-2018)
10.2 NRTs Products Sales Growth and Price
10.2.1 Global NRTs Products Sales Growth (2013-2018)
10.2.2 Global NRTs Products Price (2013-2018)
10.3 Nicotine-Free Products Sales Growth and Price
10.3.1 Global Nicotine-Free Products Sales Growth (2013-2018)
10.3.2 Global Nicotine-Free Products Price (2013-2018)
11 Global Smoking Cessation Drugs Market Segment by Application
11.1 Global Smoking Cessation Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacies Sales Growth (2013-2018)
11.3 Retail Pharmacies Sales Growth (2013-2018)
11.4 Online Pharmacies Sales Growth (2013-2018)
12 Smoking Cessation Drugs Market Forecast (2018-2023)
12.1 Global Smoking Cessation Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Smoking Cessation Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Smoking Cessation Drugs Market Forecast (2018-2023)
12.2.2 Europe Smoking Cessation Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Smoking Cessation Drugs Market Forecast (2018-2023)
12.2.4 South America Smoking Cessation Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Smoking Cessation Drugs Market Forecast (2018-2023)
12.3 Smoking Cessation Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Smoking Cessation Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Smoking Cessation Drugs Market Share Forecast by Type (2018-2023)
12.4 Smoking Cessation Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Smoking Cessation Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Smoking Cessation Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Smoking Cessation Drugs Picture
Table Product Specifications of Smoking Cessation Drugs
Figure Global Sales Market Share of Smoking Cessation Drugs by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
